Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesBTG plc: Campath Meets Primary Endpoint in Phase III Combination Therapy Trial for Chronic Lymphocytic Leukemia
BTG, 09/25/09
BTG plc, the specialty pharmaceuticals company, notes announcement by Genzyme Corporation that its randomised Phase III clinical trial investigating Campath in combination with Fludara in relapsed or refractory chronic lymphocytic leukemia patients met its primary endpoint by demonstrating a significant improvement in progression free survival.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
ARIAD Announces Full Enrollment in Phase 3 Succeed Trial Evaluating Ridaforolimus in Patients with Metastatic Sarcomas
ARIAD Pharmaceuticals, 12/18/09
Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies
Investigational New Drugs, 12/17/09
Milatuzumab – a promising new immunotherapeutic agent
Expert Opinion on Investigational Drugs, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor